Literature DB >> 26091403

The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.

Birgit Regenfuß1, Marie-Luise Dreisow1, Deniz Hos1, Sharmila Masli2, Felix Bock1, Claus Cursiefen1.   

Abstract

BACKGROUND: In the murine cornea, which is an established model for analyzing pathologic lymphatic vessel growth, phenotypic heterogeneity of the endogenous lymphatic vessels in the limbus of the cornea was previously described. In this study, the cornea of BALB/c, C57BL/6, and FVB mice with different limbal lymphangiogenic phenotypes was analyzed to identify novel candidates potentially influencing lymphatic vessel growth. METHODS AND
RESULTS: Pathway specific expression analysis of the cornea was performed to identify novel candidate genes. Corneal protein expression of the respective candidates was analyzed by fluorescent immunohistochemistry. The effect of the candidates on proliferation of human dermal lymphatic endothelial cells (HDLECs) was analyzed by BrdU proliferation ELISA. Thirteen genes were differentially regulated in corneas of mouse strains with more endogenous limbal lymphatic vessels (high-lymphangiogenic) (C57BL/6) compared to mouse strains with less endogenous limbal lymphatic vessels (low-lymphangiogenic) (BALB/c, FVB). Two candidates, Tumor necrosis factor (ligand) superfamily member 10 (Tnfsf10/Trail) and Plasminogen activator, tissue (Plat/tPA) were expressed in the cornea of BALB/c and C57BL/6 mice on the protein level. In vitro, Trail and recombinant tPA inhibited the proliferation of human dermal lymphatic endothelial cells.
CONCLUSION: Molecular analysis of the naive cornea in mouse strains with different limbal lymphatic phenotypes is a valuable model to identify novel endogenous regulators of lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26091403      PMCID: PMC4492666          DOI: 10.1089/lrb.2015.0004

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  43 in total

1.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.

Authors:  Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young-Kwon Hong
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  A model of angiogenesis in the mouse cornea.

Authors:  B M Kenyon; E E Voest; C C Chen; E Flynn; J Folkman; R J D'Amato
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-07       Impact factor: 4.799

4.  Hepatocyte growth factor promotes lymphatic vessel formation and function.

Authors:  Kentaro Kajiya; Satoshi Hirakawa; Beijia Ma; Ines Drinnenberg; Michael Detmar
Journal:  EMBO J       Date:  2005-07-28       Impact factor: 11.598

5.  VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.

Authors:  S J Oh; M M Jeltsch; R Birkenhäger; J E McCarthy; H A Weich; B Christ; K Alitalo; J Wilting
Journal:  Dev Biol       Date:  1997-08-01       Impact factor: 3.582

6.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

Authors:  M G Achen; M Jeltsch; E Kukk; T Mäkinen; A Vitali; A F Wilks; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.

Authors:  P Carmeliet; L Moons; R Lijnen; M Baes; V Lemaître; P Tipping; A Drew; Y Eeckhout; S Shapiro; F Lupu; D Collen
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.

Authors:  Veronica A Carroll; Leonid L Nikitenko; Roy Bicknell; Adrian L Harris
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-03       Impact factor: 8.311

9.  Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism.

Authors:  T H Welling; T S Huber; L M Messina; J C Stanley
Journal:  J Surg Res       Date:  1996-11       Impact factor: 2.192

Review 10.  Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.

Authors:  M S Pepper; R Montesano; S J Mandriota; L Orci; J D Vassalli
Journal:  Enzyme Protein       Date:  1996
View more
  4 in total

Review 1.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 2.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

Review 3.  Corneal Allografts: Factors for and against Acceptance.

Authors:  Justyna Sakowska; Paulina Glasner; Maciej Zieliński; Piotr Trzonkowski; Leopold Glasner
Journal:  J Immunol Res       Date:  2021-10-03       Impact factor: 4.818

4.  Cystathionine β-synthase as novel endogenous regulator of lymphangiogenesis via modulating VEGF receptor 2 and 3.

Authors:  Niloofar Hatami; Christian Büttner; Felix Bock; Sara Simfors; Gwen Musial; André Reis; Claus Cursiefen; Thomas Clahsen
Journal:  Commun Biol       Date:  2022-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.